Sunhydrogen Inc (HYSR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed May 8, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HYSR SEC filings page.
This page shows Sunhydrogen Inc (HYSR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
SunHydrogen’s R&D-funded development model relies on financing while maintaining a lightly indebted balance sheet.
In FY2025, the net loss of-$8.2M was substantially larger than operating cash flow of-$3.6M , and FY2024 showed the same direction. This recurring gap indicates that reported earnings are being shaped by non-cash or non-operating items, making cash flow the clearer measure of ongoing resource consumption.
By FY2025, liabilities were only
R&D investment rose from
Financial Health Signals
Sunhydrogen Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Sunhydrogen Inc passes 2 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Sunhydrogen Inc reported a net loss of $8.2M while operations used $3.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Sunhydrogen Inc reported an operating loss of $5.8M against $626 in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Sunhydrogen Inc's EBITDA was -$1.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 19.2% from the same quarter a year earlier. Against the prior quarter it is down 3.6%.
Sunhydrogen Inc reported -$1.5M in net income in Q3 2026. This represents an increase of 11.7% from the same quarter a year earlier. Against the prior quarter it is down 2.4%.
Not reported for Q3 2026.
Cash & Balance Sheet
Sunhydrogen Inc held $13.1M in cash as of Q3 2026; long-term debt is not reported for that period.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Sunhydrogen Inc's ROE was -4.7% in Q3 2026, measuring profit generated per dollar of shareholder equity. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
Sunhydrogen Inc invested $943K in research and development in Q3 2026. This represents a decrease of 16.9% from the same quarter a year earlier. Against the prior quarter it is down 2.7%.
Not reported for Q3 2026.
Not reported for Q3 2026.
HYSR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | $1K | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $943K-16.9% | $969K+54.7% | $1.2M+97.2% | N/A | $1.1M+51.2% | $626K-17.2% | $608K+38.5% | N/A |
| SG&A Expenses | $731K-26.4% | $667K+7.4% | $706K+68.6% | N/A | $993K-7.2% | $622K+24.9% | $419K-17.0% | N/A |
| Operating Income | -$1.7M+19.1% | -$1.7M-32.7% | -$1.9M-85.6% | N/A | -$2.1M-16.7% | -$1.3M+0.5% | -$1.0M-3.8% | N/A |
| EBITDA | -$1.7M+19.2% | -$1.7M-32.9% | -$1.9M-86.3% | N/A | -$2.1M-16.8% | -$1.2M+0.5% | -$1.0M-4.0% | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | $83-95.2% | $543-67.9% | N/A |
| Net Income | -$1.5M+11.7% | -$1.5M+56.8% | -$1.6M+23.8% | N/A | -$1.7M+56.8% | -$3.5M-14.6% | -$2.0M-356.8% | N/A |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted Shares (Avg) | 5.52B+1.5% | 5.44B+2.5% | 5.44B+6.6% | N/A | 5.44B+6.7% | 5.30B+4.6% | 5.10B+5.0% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Income Tax.
HYSR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $33.9M-12.0% | $34.5M-13.8% | $35.7M-17.6% | $37.9M-12.6% | $38.6M-15.1% | $40.0M-17.8% | $43.4M-15.0% | $43.4M-15.3% |
| Current Assets | $33.8M-12.0% | $34.3M-13.8% | $35.5M-17.6% | $37.7M-12.6% | $38.4M-9.2% | $39.8M-12.5% | $43.1M-9.9% | $43.1M-10.2% |
| Cash & Equivalents | $13.1M-59.4% | $14.4M-63.6% | $33.5M-17.4% | $34.6M-11.3% | $32.2M-17.9% | $39.6M+14.1% | $40.5M+16.0% | $39.0M+5.0% |
| Short-Term Investments | $19.8M+227.3% | $19.8M | $2.0M | $3.0M | $6.1M | $0 | $0-100.0% | $0-100.0% |
| Accounts Receivable | N/A | N/A | $1K | N/A | N/A | N/A | N/A | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% |
| Total Liabilities | $725K+78.4% | $741K+41.5% | $767K+30.7% | $675K-11.1% | $406K-19.4% | $523K-15.6% | $587K+73.5% | $760K+101.5% |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $760K+123.2% |
| Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% |
| Total Equity | $32.9M-12.1% | $33.2M-14.4% | $34.5M-17.8% | $36.6M-12.3% | $37.5M-14.8% | $38.8M-17.7% | $41.9M-15.9% | $41.7M-16.1% |
| Retained Earnings | -$104.7M-5.6% | -$103.1M-5.9% | -$101.6M-8.2% | -$100.1M-9.0% | -$99.1M-10.8% | -$97.4M-14.0% | -$93.9M-13.9% | -$91.9M-12.1% |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
HYSR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.6M-11.0% | -$1.1M-28.4% | -$1.2M-68.5% | -$676K-838.3% | -$1.4M-70.6% | -$865K-82.4% | -$704K-48.3% | -$72K+92.1% |
| Depreciation & Amortization | $10K+9.1% | $10K+5.3% | $10K+9.1% | N/A | $9K-9.9% | $10K-10.1% | $9K-15.0% | N/A |
| Stock-Based Compensation | N/A | N/A | $279K+2699.0% | N/A | N/A | N/A | $10K-86.2% | N/A |
| Investing Cash Flow | -$108K | -$17.9M | $1.0M | $3.1M+3992.9% | N/A | N/A | N/A | -$80K-101.1% |
| Financing Cash Flow | $332K | $0+100.0% | -$1.0M-146.2% | $0+100.0% | $0-100.0% | -$9K-103.5% | $2.2M+894.1% | -$19K-102.4% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
HYSR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | N/A | -153851.6% | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | -124782.2% | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | -4.7%0.0pp | -4.5%+4.4pp | -4.5%+0.4pp | N/A | -4.6%+4.5pp | -8.9%-2.5pp | -4.9%-4.0pp | N/A |
| Return on Assets | -4.5%0.0pp | -4.3%+4.3pp | -4.4%+0.4pp | N/A | -4.5%+4.3pp | -8.7%-2.5pp | -4.7%-3.8pp | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 56.81-84.4x |
| Debt-to-Equity | 0.020.0x | 0.020.0x | 0.020.0x | 0.020.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.020.0x |
| Asset Turnover | N/A | N/A | 0.00 | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Gross Margin, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Sunhydrogen Inc HYSR | FY2025 | N/A | -$8.2M | N/A | $104.2M | — |
| Singlepoint Inc SING | FY2024 | $20.3M | -$28.9M | N/A | $20K | — |
| Geosolar Tech GSLR | FY2023 | N/A | -$2.8M | N/A | $852K | — |
Where Sunhydrogen Inc Ranks
Frequently Asked Questions
Is Sunhydrogen Inc profitable?
No, Sunhydrogen Inc (HYSR) reported a net income of -$8.2M in fiscal year 2025.
What is Sunhydrogen Inc's EBITDA?
Sunhydrogen Inc (HYSR) had EBITDA of -$5.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Sunhydrogen Inc's return on equity (ROE)?
Sunhydrogen Inc (HYSR) has a return on equity of -22.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Sunhydrogen Inc's free cash flow?
Sunhydrogen Inc (HYSR) recorded an outflow of $3.7M in free cash flow during fiscal year 2025. This represents a -96.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Sunhydrogen Inc's operating cash flow?
Sunhydrogen Inc (HYSR) recorded an outflow of $3.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Sunhydrogen Inc's total assets?
Sunhydrogen Inc (HYSR) had $37.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Sunhydrogen Inc's capital expenditures?
Sunhydrogen Inc (HYSR) invested $17K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Sunhydrogen Inc spend on research and development?
Sunhydrogen Inc (HYSR) invested $3.4M in research and development during fiscal year 2025.
What is Sunhydrogen Inc's debt-to-equity ratio?
Sunhydrogen Inc (HYSR) had a debt-to-equity ratio of 0.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Sunhydrogen Inc's return on assets (ROA)?
Sunhydrogen Inc (HYSR) had a return on assets of -21.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Sunhydrogen Inc's P/E ratio?
Sunhydrogen Inc (HYSR) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $104.2M as of Sep 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Sunhydrogen Inc's price-to-sales ratio?
Sunhydrogen Inc (HYSR) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $104.2M as of Sep 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Sunhydrogen Inc's Piotroski F-Score?
Sunhydrogen Inc (HYSR) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Sunhydrogen Inc's earnings high quality?
Sunhydrogen Inc (HYSR) reported a net loss of $8.2M while operations used $3.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Sunhydrogen Inc cover its interest payments?
Sunhydrogen Inc (HYSR) reported an operating loss of $5.8M against $626 in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.